Ikarian Capital’s Chiasma, Inc. Common Stock CHMA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-90,437
Closed -$428K 266
2021
Q2
$428K Sell
90,437
-519,862
-85% -$1.96M 0.03% 193
2021
Q1
$1.91M Sell
610,299
-120,000
-16% -$460K 0.06% 201
2020
Q4
$3.18M Sell
730,299
-899,334
-55% -$3.75M 0.14% 124
2020
Q3
$7.01M Buy
1,629,633
+200,000
+14% +$958K 0.51% 51
2020
Q2
$7.69M Sell
1,429,633
-645,859
-31% -$3.56M 0.61% 52
2020
Q1
$7.58M Buy
2,075,492
+972,195
+88% +$4.31M 0.57% 45
2019
Q4
$5.47M Buy
+1,103,297
New +$5.74M 0.89% 36

Ikarian Capital's CHMA Position: Q3 2021 in Review

Ikarian Capital sold out of Chiasma, Inc. Common Stock (CHMA) in Q3 2021, closing a stake of 90,437 shares — an estimated $428K sold.

Ikarian Capital first reported a position in CHMA in Q4 2019 and held it in 7 quarters. The position peaked at $7.69M in Q2 2020. 0 funds tracked by Wall St. Rank hold CHMA as of Q3 2021.

  • Ikarian Capital reported no remaining Chiasma, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • Ikarian Capital sold 90,437 Chiasma, Inc. Common Stock shares in Q3 2021, an estimated $428K.
  • Ikarian Capital first reported a position in Chiasma, Inc. Common Stock in Q4 2019 and held it in 7 quarters.
  • Ikarian Capital's Chiasma, Inc. Common Stock position peaked at $7.69M in Q2 2020.
  • 0 funds tracked by Wall St. Rank held Chiasma, Inc. Common Stock as of Q3 2021.

Based on Ikarian Capital's 13F filing for Q3 2021, filed 15 Nov 2021.